Future Horizons and Growth Strategies in the US Hemostasis Diagnostic Testing Market 2015: Supplier Shares and Country Forecasts
Complete report $9,600. DataPack (test volumes, sales forecasts, supplier shares) $6,200.
Summary
This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the next five years. The report explores business and technological trends in the US coagulation testing market; provides estimates of the test volume, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years. Coagulation TestsActivated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time, D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX, Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation, Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen, Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S, Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time, Von Willebrand's Factor Fav/Ag, and others
Sales and Market Share Analysis
Sales and market shares of major instrument and reagent suppliers.
Competitive Assessments
Extensive strategic profiles of major suppliers and emerging market entrants. Market Segmentation Analysis- Comprehensive market segmentation analysis, including: - Hospitals - Commercial/Private Laboratories - Physician Offices- Test volume forecasts for over 40 major procedures by market segment. Current and Emerging Products- Review of established and emerging procedures. - Comparison of automated and semi-automated analyzers from Diagnostica Stago, Helena, IL, Siemens, Sysmex and other suppliers. Technology Review- Analysis of current and emerging technologies and their potential market applications. - Comprehensive lists of companies developing or marketing new technologies and products by test.
Strategic Recommendations
Product development and business expansion opportunities with significant market appeal. - Ideal product models with tentative prices and operating characteristics. - Alternative market penetration strategies for instrument and reagent suppliers. - Potential market entry barriers and risks.
Contains 424 pages and 37 tables
Summary
This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the next five years. The report explores business and technological trends in the US coagulation testing market; provides estimates of the test volume, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years. Coagulation TestsActivated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time, D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX, Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation, Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen, Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S, Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time, Von Willebrand's Factor Fav/Ag, and others
Sales and Market Share Analysis
Sales and market shares of major instrument and reagent suppliers.
Competitive Assessments
Extensive strategic profiles of major suppliers and emerging market entrants. Market Segmentation Analysis- Comprehensive market segmentation analysis, including: - Hospitals - Commercial/Private Laboratories - Physician Offices- Test volume forecasts for over 40 major procedures by market segment. Current and Emerging Products- Review of established and emerging procedures. - Comparison of automated and semi-automated analyzers from Diagnostica Stago, Helena, IL, Siemens, Sysmex and other suppliers. Technology Review- Analysis of current and emerging technologies and their potential market applications. - Comprehensive lists of companies developing or marketing new technologies and products by test.
Strategic Recommendations
Product development and business expansion opportunities with significant market appeal. - Ideal product models with tentative prices and operating characteristics. - Alternative market penetration strategies for instrument and reagent suppliers. - Potential market entry barriers and risks.
Contains 424 pages and 37 tables
INTRODUCTION
WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Major Routine and Special Hemostasis Tests
1. Introduction
2. Activated Partial Thromboplastin Time (APTT)
3. Alpha-2 Antiplasmin
4. Antithrombin III
5. Bleeding Time
6. D-Dimer
7. Ethanol Flocculation Test
8. Euglobulin Lysis
9. Factor Assays
a. Introduction
b. Factor II
c. Factor V/Factor V Leiden
d. Factor VII
e. Factor VIII
f. Factor IX
g. Factor IXa
h. Factor X (Stuart Factor)
i. Factor Xa
j. Factor XI
k. Factor XII
l. Factor XIII
10. Fibrin Degradation Products
11. Fibrinogen
12. Heparin
13. Hirudin
14. Hypercoagulability and Thrombosis
15. Lipoprotein a
16. Plasmin
17. Plasminogen
18. Plasminogen Activator Inhibitor (PAI)
19. Platelet Function Tests
20. Platelet Aggregation
21. Proteins C and S
22. Prothrombin Fragment 1.2
23. Prothrombin Time (PT)
24. Reptilase Time
25. Thrombin Time
26. Tissue-Type Plasminogen Activator (t-PA)
27. Von Willebrand's Factor
B. Instrumentation Review
Introduction
Benk Hemolab
Benk TRT Thrombotimer
Bio/Data MCA
Bio/Data MCA
Bio/Data PAP-4C D/4D/4C
Cardiovascular Diagnostics COAG
Diagnostica Stago STA Compact
Diagnostica Stago STA-R
Diagnostica Stago Star 4/8
Helena Laboratories Cascade
Helena Laboratories Cascade M
Helena Laboratories PACKS-4
Helena THOR
Instrumentation Laboratory ACL 100 and 1000 series
Instrumentation Laboratory ACL6000
Instrumentation Laboratory ACL7000
Instrumentation Laboratory ACL9000
Instrumentation Laboratory Electra 1000C
Instrumentation Laboratory Electra 1400C
Instrumentation Laboratory Electra 1600/C
Instrumentation Laboratory Electra 1800C
Instrumentation Laboratory Futura
ITC Hemochron 8000
Roche Diagnostics CoaguChek
Siemens BCS
Siemens BCT
Siemens BF II/Fibrintimer Series
Sysmex CA-50
Sysmex CA-500
Sysmex CA-1500
Sysmex CA-5000/CA-1000
Sysmex CA-6000
Sysmex CA-7000
Teco Coatron II/Jr./AccuStasis 5000
Trinity Biotech Amax CS190
Trinity Biotech Amax CS400
Trinity Biotech Coag-A-Mate Max
Trinity Biotech KC 40, 4A, 1A Series
Trinity Biotech MDA
Trinity Biotech Coag-A-Mate MTX
Trinity Biotech Coag-A-Mate RA4
Trinity Biotech Coag-A-Mate XC/Plus
Trinity Biotech Coag-A-Mate XM
C. Major in Vitro Diagnostic Technologies and Their Potential Applications
1. Chromogenic Substrates
2. Monoclonal and Polyclonal Antibodies
3. Immunoassays
a. Applications
b. Technological Principle
c. Enzyme Immunoassays (EIA)
Overview
ELISA
EMIT
Dot Immunobinding Assays
Capillary Immunoassays
Enzyme Amplification
Electrochemical Immunoassay
d. Fluorescent Immunoassays
Fluorescence Polarization
Time-Resolved Pulse Fluorescence
Fluorescence Lifetime
e. Latex Agglutination
f. Immunoprecipitation
4. Microcomputers
5. Automation
6. Robotics
7. DNA Probes
a. Overview
b. Amplification Methods
PCR
Ligase Chain Reaction
Branched DNA
Q-Beta Replicase
NASBA
SDA
3 SR
HPA
Two-Tiered System
LAT
8. Artificial Intelligence
9. Dry Chemistry
10. Biosensors
D. Worldwide Market Overview
1. Business Environment
2. Market Structure
3. Market Size and Growth
4. POC Testing Market
USA
A. Executive Summary
B. Business Environment
1. Health Care Expenditures
2. Cost Consciousness
3. Industry Consolidation
4. Managed Care
5. Hospitals
6. Admissions
7. Length of Stay
8. Industry Diversification
9. Physician Demographics
10. Population Aging
a. Chronic Illnesses
b. Disease Incidence
c. Susceptibility to Iatrogenesis
d. Multiple Illness Cases
11. Laboratory Regulations
C. Market Structure
1. Centralized Testing
a. Hospitals
b. Commercial laboratories
2. Decentralized Testing
a. Physician Offices/Group Practices
b. Point-of-Care Testing
c. Home/Self Testing
d. Other Decentralized Testing Locations
D. Market Size, Growth And Major Suppliers
MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types Of Distributors
7. Market Segmentation
POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
COMPETITIVE ASSESSMENTS
Abbott
American Diagnostica
Avocet Medical
Axis-Shield
Beckman Coulter
Becton Dickinson
Bio/Data Corporation
Biosite
Chrono-Log
Corgenix Medical
Diagnostica Stago
Helena Laboratories
HYPEN BioMed
Instrumentation Laboratory
ITC
Nanogen
Roche
Siemens
Sienco
Sysmex
Thermo Fischer
Trinity Biotech
ZyCare
WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Major Routine and Special Hemostasis Tests
1. Introduction
2. Activated Partial Thromboplastin Time (APTT)
3. Alpha-2 Antiplasmin
4. Antithrombin III
5. Bleeding Time
6. D-Dimer
7. Ethanol Flocculation Test
8. Euglobulin Lysis
9. Factor Assays
a. Introduction
b. Factor II
c. Factor V/Factor V Leiden
d. Factor VII
e. Factor VIII
f. Factor IX
g. Factor IXa
h. Factor X (Stuart Factor)
i. Factor Xa
j. Factor XI
k. Factor XII
l. Factor XIII
10. Fibrin Degradation Products
11. Fibrinogen
12. Heparin
13. Hirudin
14. Hypercoagulability and Thrombosis
15. Lipoprotein a
16. Plasmin
17. Plasminogen
18. Plasminogen Activator Inhibitor (PAI)
19. Platelet Function Tests
20. Platelet Aggregation
21. Proteins C and S
22. Prothrombin Fragment 1.2
23. Prothrombin Time (PT)
24. Reptilase Time
25. Thrombin Time
26. Tissue-Type Plasminogen Activator (t-PA)
27. Von Willebrand's Factor
B. Instrumentation Review
Introduction
Benk Hemolab
Benk TRT Thrombotimer
Bio/Data MCA
Bio/Data MCA
Bio/Data PAP-4C D/4D/4C
Cardiovascular Diagnostics COAG
Diagnostica Stago STA Compact
Diagnostica Stago STA-R
Diagnostica Stago Star 4/8
Helena Laboratories Cascade
Helena Laboratories Cascade M
Helena Laboratories PACKS-4
Helena THOR
Instrumentation Laboratory ACL 100 and 1000 series
Instrumentation Laboratory ACL6000
Instrumentation Laboratory ACL7000
Instrumentation Laboratory ACL9000
Instrumentation Laboratory Electra 1000C
Instrumentation Laboratory Electra 1400C
Instrumentation Laboratory Electra 1600/C
Instrumentation Laboratory Electra 1800C
Instrumentation Laboratory Futura
ITC Hemochron 8000
Roche Diagnostics CoaguChek
Siemens BCS
Siemens BCT
Siemens BF II/Fibrintimer Series
Sysmex CA-50
Sysmex CA-500
Sysmex CA-1500
Sysmex CA-5000/CA-1000
Sysmex CA-6000
Sysmex CA-7000
Teco Coatron II/Jr./AccuStasis 5000
Trinity Biotech Amax CS190
Trinity Biotech Amax CS400
Trinity Biotech Coag-A-Mate Max
Trinity Biotech KC 40, 4A, 1A Series
Trinity Biotech MDA
Trinity Biotech Coag-A-Mate MTX
Trinity Biotech Coag-A-Mate RA4
Trinity Biotech Coag-A-Mate XC/Plus
Trinity Biotech Coag-A-Mate XM
C. Major in Vitro Diagnostic Technologies and Their Potential Applications
1. Chromogenic Substrates
2. Monoclonal and Polyclonal Antibodies
3. Immunoassays
a. Applications
b. Technological Principle
c. Enzyme Immunoassays (EIA)
Overview
ELISA
EMIT
Dot Immunobinding Assays
Capillary Immunoassays
Enzyme Amplification
Electrochemical Immunoassay
d. Fluorescent Immunoassays
Fluorescence Polarization
Time-Resolved Pulse Fluorescence
Fluorescence Lifetime
e. Latex Agglutination
f. Immunoprecipitation
4. Microcomputers
5. Automation
6. Robotics
7. DNA Probes
a. Overview
b. Amplification Methods
PCR
Ligase Chain Reaction
Branched DNA
Q-Beta Replicase
NASBA
SDA
3 SR
HPA
Two-Tiered System
LAT
8. Artificial Intelligence
9. Dry Chemistry
10. Biosensors
D. Worldwide Market Overview
1. Business Environment
2. Market Structure
3. Market Size and Growth
4. POC Testing Market
USA
A. Executive Summary
B. Business Environment
1. Health Care Expenditures
2. Cost Consciousness
3. Industry Consolidation
4. Managed Care
5. Hospitals
6. Admissions
7. Length of Stay
8. Industry Diversification
9. Physician Demographics
10. Population Aging
a. Chronic Illnesses
b. Disease Incidence
c. Susceptibility to Iatrogenesis
d. Multiple Illness Cases
11. Laboratory Regulations
C. Market Structure
1. Centralized Testing
a. Hospitals
b. Commercial laboratories
2. Decentralized Testing
a. Physician Offices/Group Practices
b. Point-of-Care Testing
c. Home/Self Testing
d. Other Decentralized Testing Locations
D. Market Size, Growth And Major Suppliers
MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types Of Distributors
7. Market Segmentation
POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
COMPETITIVE ASSESSMENTS
Abbott
American Diagnostica
Avocet Medical
Axis-Shield
Beckman Coulter
Becton Dickinson
Bio/Data Corporation
Biosite
Chrono-Log
Corgenix Medical
Diagnostica Stago
Helena Laboratories
HYPEN BioMed
Instrumentation Laboratory
ITC
Nanogen
Roche
Siemens
Sienco
Sysmex
Thermo Fischer
Trinity Biotech
ZyCare
LIST OF TABLES
Major Companies Developing or Marketing Activated Clotting Time Tests
Major Companies Developing or Marketing APTT Tests
Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests
Major Companies Developing or Marketing Antithrombin III Tests
Major Companies Developing or Marketing Bleeding Time Tests
Major Companies Developing or Marketing D-dimer Tests
Major Companies Developing or Marketing Factor Assays
Major Companies Developing or Marketing Fibrin Degradation Product Tests
Major Companies Developing or Marketing Fibrinogen Tests
Major Companies Developing or Marketing Heparin Tests
Major Companies Developing or Marketing Plasmin Tests
Major Companies Developing or Marketing Plasminogen Tests
Major Companies Developing or Marketing Plasminogen Activator Inhibitor Tests
Major Companies Developing or Marketing Platelet Aggregation Tests
Major Companies Developing or Marketing Protein C Tests
Major Companies Developing or Marketing Protein S Tests
Major Companies Developing or Marketing PT Tests
Major Companies Developing or Marketing Thrombin Time Tests
Major Companies Developing or Marketing TPA Tests
Major Companies Developing or Marketing Von Willebrand's Factor Tests
Worldwide, All Market Segments, Laboratories Performing Hemostasis Tests By Country, 2010
Worldwide, All Market Segments, Total Hemostasis Test Volume By Country, 2010-2020
Worldwide, All Market Segments, Total Hemostasis Reagent Market By Country, 2010-2020
Worldwide, All Market Segments, Total Hemostasis Instrument Market By Country, 2010-2020
Worldwide, All Market Segments, Total Hemostasis Diagnostics Market By Country, 2010-2020
Executive Summary Table: U.S.A., Total Hemostasis Diagnostics Market By Market Segment and Product Category, 2010-2020
U.S.A., Laboratories Performing Hemostasis Tests By Market Segment, 2010
U.S.A., Hospital Laboratories Performing Hemostasis Tests By Bed Size, 2010
U.S.A., Commercial/Private Laboratories Performing Hemostasis Tests By Annual Test Volume, 2010
U.S.A., Physician Offices/Group Practices Performing Hemostasis Tests By Practice Size, 2010
U.S.A., Hospital Laboratories Average Daily Test Volume, 2010
U.S.A., Commercial/Private Laboratories Average Daily Test Volume, 2010
U.S.A., Physician Offices/Group Practices Average Daily Test Volume
U.S.A., Total Hemostasis Test Volume By Market Segment, 2010-2020
U.S.A., All Market Segments Hemostasis Test Volume, 2010-2020
U.S.A., Hospital Laboratories Hemostasis Test Volume, 2010-2020
U.S.A., Physician Offices/Group Practices Hemostasis Test Volume, 2010-2020
U.S.A., Commercial/Private Laboratories Hemostasis Test Volume, 2010-2020
U.S.A., Hemostasis Reagent Market By Market Segment, 2010-2020
U.S.A., Major Suppliers of Hemostasis Reagents Estimated Sales and Market Shares, 2010
U.S.A., Hemostasis Instrument Market By Market Segment, 2010-2020
U.S.A., Major Suppliers of Hemostasis Analyzers, Estimated Total Instrument Placements and Market Shares, 2010
U.S.A., Major Suppliers of Hemostasis Analyzers, Estimated Placements and Installed Base By Supplier and Model, 2010
U.S.A., Major Suppliers of Hemostasis Analyzers, Estimated Instrument Sales and Market Shares, 2010
U.S.A., Total Hemostasis Diagnostics Market By Product Category, 2010-2020
U.S.A., Major Suppliers of Hemostasis Diagnostic Products, Estimated Sales and Market Shares, 2010
Major Companies Developing or Marketing Activated Clotting Time Tests
Major Companies Developing or Marketing APTT Tests
Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests
Major Companies Developing or Marketing Antithrombin III Tests
Major Companies Developing or Marketing Bleeding Time Tests
Major Companies Developing or Marketing D-dimer Tests
Major Companies Developing or Marketing Factor Assays
Major Companies Developing or Marketing Fibrin Degradation Product Tests
Major Companies Developing or Marketing Fibrinogen Tests
Major Companies Developing or Marketing Heparin Tests
Major Companies Developing or Marketing Plasmin Tests
Major Companies Developing or Marketing Plasminogen Tests
Major Companies Developing or Marketing Plasminogen Activator Inhibitor Tests
Major Companies Developing or Marketing Platelet Aggregation Tests
Major Companies Developing or Marketing Protein C Tests
Major Companies Developing or Marketing Protein S Tests
Major Companies Developing or Marketing PT Tests
Major Companies Developing or Marketing Thrombin Time Tests
Major Companies Developing or Marketing TPA Tests
Major Companies Developing or Marketing Von Willebrand's Factor Tests
Worldwide, All Market Segments, Laboratories Performing Hemostasis Tests By Country, 2010
Worldwide, All Market Segments, Total Hemostasis Test Volume By Country, 2010-2020
Worldwide, All Market Segments, Total Hemostasis Reagent Market By Country, 2010-2020
Worldwide, All Market Segments, Total Hemostasis Instrument Market By Country, 2010-2020
Worldwide, All Market Segments, Total Hemostasis Diagnostics Market By Country, 2010-2020
Executive Summary Table: U.S.A., Total Hemostasis Diagnostics Market By Market Segment and Product Category, 2010-2020
U.S.A., Laboratories Performing Hemostasis Tests By Market Segment, 2010
U.S.A., Hospital Laboratories Performing Hemostasis Tests By Bed Size, 2010
U.S.A., Commercial/Private Laboratories Performing Hemostasis Tests By Annual Test Volume, 2010
U.S.A., Physician Offices/Group Practices Performing Hemostasis Tests By Practice Size, 2010
U.S.A., Hospital Laboratories Average Daily Test Volume, 2010
U.S.A., Commercial/Private Laboratories Average Daily Test Volume, 2010
U.S.A., Physician Offices/Group Practices Average Daily Test Volume
U.S.A., Total Hemostasis Test Volume By Market Segment, 2010-2020
U.S.A., All Market Segments Hemostasis Test Volume, 2010-2020
U.S.A., Hospital Laboratories Hemostasis Test Volume, 2010-2020
U.S.A., Physician Offices/Group Practices Hemostasis Test Volume, 2010-2020
U.S.A., Commercial/Private Laboratories Hemostasis Test Volume, 2010-2020
U.S.A., Hemostasis Reagent Market By Market Segment, 2010-2020
U.S.A., Major Suppliers of Hemostasis Reagents Estimated Sales and Market Shares, 2010
U.S.A., Hemostasis Instrument Market By Market Segment, 2010-2020
U.S.A., Major Suppliers of Hemostasis Analyzers, Estimated Total Instrument Placements and Market Shares, 2010
U.S.A., Major Suppliers of Hemostasis Analyzers, Estimated Placements and Installed Base By Supplier and Model, 2010
U.S.A., Major Suppliers of Hemostasis Analyzers, Estimated Instrument Sales and Market Shares, 2010
U.S.A., Total Hemostasis Diagnostics Market By Product Category, 2010-2020
U.S.A., Major Suppliers of Hemostasis Diagnostic Products, Estimated Sales and Market Shares, 2010
